Definitive Contract 00261200207D261027010
Award Date 8/1/02
Potential Completion Date 2/29/08
Potential Value $81M
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Fisher Bioservices Inc., a division of Thermo Electron Corporation, for the storage and distribution of clinical agents. The contract has a potential value of $29,398,963.86 and is a cost plus fixed fee arrangement. The contract does not have a set-aside designation. As a prime contractor, Fisher Bioservices provides a variety of goods and services to...
- Fisher Bioservices Inc., a division of Thermo Electron Corporation, was awarded a $1,315,665.00 delivery order contract by the Department of Health and Human Services National Institutes of Health National Cancer Institute. The contract is for the registration, storage, and distribution of chemicals and drugs for pre-clinical discovery evaluation. This is a firm fixed-price contract with a completion date of March 31, 2023. No set-aside designation was used for this award. Fisher Bioservices...
- The National Cancer Institute (NCI) awarded this delivery order contract to Fisher Bioservices Inc., Clinical Trials Division (a subsidiary of Thermo Electron Corporation) on June 1, 2017, for the registration, storage, and distribution of chemicals and drugs for preclinical discovery evaluation and development. The contract, valued at $117,864.84 with a firm fixed price structure, was performed at the contractor's facility in Rockville, Maryland, and carried an ultimate completion date of...
- The National Institutes of Health National Cancer Institute awarded a $5.3 million delivery order contract to Fisher Bioservices Clinical Trials Division for the registration, storage, and distribution of chemicals and drugs in support of pre-clinical discovery, evaluation, and development efforts. Under the cost-plus-fixed-fee contract running from March 2021 through February 2023, Fisher Bioservices will provide services for the handling and management of chemicals and compounds as the NIH...
- This is a $40,769,874.54 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Fisher Bioservices Inc. Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract has no set-aside designation. The contract supports a variety of biomedical research and public health initiatives, including the management and distribution of biological specimens, cell...
- This federal contract award, valued at $149,777.24, was made by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for off-site storage of refrigerated, cryopreserved, and frozen biological materials. This delivery order contract is part of the Scientific Equipment and Services (FSS-66) schedule under the General Services Administration (GSA). The contract does not have a set-aside designation. Fisher Bioservices is an...
- This is a $98,483,014.02 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Fisher BioServices Inc., a subsidiary of Thermo Electron Corporation, for the NIAID Clinical Research Products Management Center (CRPMC). The contract is for the provision of comprehensive solutions including storage, maintenance, distribution, and occasional destruction of biological specimens, clinical materials, pharmaceuticals, and research-related compounds...
- The National Cancer Institute awarded a definitive contract to Fisher Bioservices Inc. for housekeeping, warehousing, storage, and distribution of clinical agents on March 12, 2013, with a ceiling value of $16.427 million under cost-plus-fixed-fee pricing and no set-aside category. Place of performance is Rockville, MD. The contract's ultimate completion date is January 31, 2018. Fisher Bioservices Inc. operates as the Clinical Trials Division of Thermo Electron Corporation and provides...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Fisher Bioservices Inc. for the storage of cryopreserved cells for a period of one year. The contract is valued at $78,265.52 and is not set aside. Fisher Bioservices Inc. is a subsidiary of Thermo Electron Corporation, which is a major provider of scientific instruments and services to federal agencies. This contract is part of Fisher Bioservices' broader work supporting...
- This is a federal contract award to Fisher Bioservices Inc. Clinical Trials Division, a subsidiary of Thermo Electron Corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $28,498.95, is for the provision of materials stored in Fisher Bioservices-owned equipment on a monthly basis. The contract is an open market award, with no set-aside designation. Fisher Bioservices has extensive...